Nautilus Biotechnology, Inc.

NASDAQ:NAUT

1.76 (USD) • At close December 20, 2024
Bedrijfsnaam Nautilus Biotechnology, Inc.
Symbool NAUT
Munteenheid USD
Prijs 1.76
Beurswaarde 220,992,640
Dividendpercentage 0%
52-weken bereik 1.74 - 3.455
Industrie Biotechnology
Sector Healthcare
CEO Mr. Sujal M. Patel
Website https://www.nautilus.bio

An error occurred while fetching data.

Over Nautilus Biotechnology, Inc.

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is

Vergelijkbare Aandelen

Karyopharm Therapeutics Inc. logo

Karyopharm Therapeutics Inc.

KPTI

0.635 USD

2seventy bio, Inc. logo

2seventy bio, Inc.

TSVT

3.14 USD

Immatics N.V. logo

Immatics N.V.

IMTX

6.85 USD

Atara Biotherapeutics, Inc. logo

Atara Biotherapeutics, Inc.

ATRA

11.4 USD

Arcturus Therapeutics Holdings Inc. logo

Arcturus Therapeutics Holdings Inc.

ARCT

15.48 USD

Cara Therapeutics, Inc. logo

Cara Therapeutics, Inc.

CARA

0.423 USD

Immunovant, Inc. logo

Immunovant, Inc.

IMVT

25.86 USD

908 Devices Inc. logo

908 Devices Inc.

MASS

2.06 USD

Vera Therapeutics, Inc. logo

Vera Therapeutics, Inc.

VERA

42.6 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)